Luca Emili is the CEO of InSilicoTrials and previously held the position of CEO at Promeditec. Emili is also a member of the Cloud Security Consultative Group at the European Medicines Agency and has experience as a partner at Gelf Capital srl. Additionally, Emili has a background in mergers and acquisitions at Studio Rock Commercialisti Associati. Educationally, Emili holds a degree in Economy from the University of Trieste and a diploma in Computer and Information Sciences from Liceo Scientifco Oberdan.
Links